Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed) | PAR 23 301

Opportunity Information: Apply for PAR 23 301

This funding opportunity, PAR 23 301, is a National Institutes of Health (NIH) discretionary grant announcement for an R21 exploratory/developmental research project titled "Developing novel theory and methods for understanding the genetic architecture of complex human traits (Clinical Trial Not Allowed)." The central purpose is to support early-stage, innovative work that creates new theory and new analytical or computational methods to better explain why complex human traits vary across people, families, and populations. Rather than focusing on running an intervention study, the program is aimed at methodological advances that clarify how genetic factors and non-genetic influences jointly shape outcomes, especially when those influences interact across different contexts.

The scope emphasizes complex traits, meaning traits influenced by many genetic variants and many environmental or social factors rather than a single gene or single cause. Projects are expected to move beyond simplistic, one-layer explanations by explicitly modeling how influences at multiple levels connect to one another. This includes interdependencies across biological scales (for example, molecular pathways, cells, tissues, organs, and whole-body physiology) and across broader social and ecological scales (for example, families, neighborhoods, policies, cultural contexts, and environmental exposures). A strong fit would be work that takes seriously the idea that individuals are embedded in families and communities, that environments are structured, and that these structures can correlate with or shape genetic patterns in ways that matter for interpretation.

NIH is looking for interdisciplinary approaches that combine perspectives and tools from the natural sciences and the social sciences. In practical terms, that could mean methods that integrate genetics with demography, sociology, economics, psychology, epidemiology, biostatistics, computational biology, or other relevant fields. The announcement highlights theory, simulations, and rigorous validation as major expectations. Applicants are encouraged to build formal frameworks, test them via simulated data where truth is known, and then validate performance using existing large-scale datasets. The focus on validation using available data signals that proposals should demonstrate feasibility and credibility without relying on launching new clinical trials or prospective interventions.

Because this is an R21, the emphasis is on high-risk, high-reward development work that can open up new research directions, produce proof-of-concept results, or create broadly useful tools and frameworks. The listed award ceiling is $275,000, consistent with the exploratory nature of the mechanism, and the clinical trial restriction means the proposed research should not involve assigning human participants to interventions to evaluate health-related outcomes. Instead, typical eligible activities would include methodological development, secondary analysis of existing datasets, integrative modeling, simulation studies, and development of software or statistical frameworks, as long as they align with NIH policies and the announcement requirements.

Eligibility is broad and includes many types of U.S. organizations: state, county, city, and township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofit organizations (both 501(c)(3) and non-501(c)(3), excluding higher education institutions where specified); for-profit organizations other than small businesses; and small businesses. The opportunity also explicitly calls out additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and non-U.S. entities (foreign organizations). This broad eligibility suggests NIH is seeking diverse institutional perspectives and capabilities, including those rooted in communities that are often underrepresented in genomics and population research.

Key administrative details from the source include the funding activity category (Health), CFDA number 93.172, and an original closing date of 2027-01-07, indicating multiple potential receipt cycles over time under this announcement. Overall, the opportunity is best understood as support for building the next generation of conceptual and analytical tools for studying complex trait architecture in humans, with particular attention to the real-world entanglement of genes, environments, and social structures, and with a strong preference for theory-driven, simulation-tested, and dataset-validated methodological innovation.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.172.
• This funding opportunity was created on 2023-09-26.
• Applicants must submit their applications by 2027-01-07.
• Each selected applicant is eligible to receive up to $275,000.00 in funding.
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for PAR 23 301

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: